These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16225475)

  • 1. Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link.
    Ratziu V; Heurtier A; Bonyhay L; Poynard T; Giral P
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():56-60. PubMed ID: 16225475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus and glucose and lipid metabolism.
    Alaei M; Negro F
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus.
    Kwon SY; Kim SS; Kwon OS; Kwon KA; Chung MG; Park DK; Kim YS; Koo YS; Kim YK; Choi DJ; Kim JH
    Diabet Med; 2005 Nov; 22(11):1530-5. PubMed ID: 16241918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications.
    Adinolfi LE; Durante-Mangoni E; Zampino R; Ruggiero G
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():52-5. PubMed ID: 16225474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients.
    Taura N; Ichikawa T; Hamasaki K; Nakao K; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Abiru N; Yamasaki H; Eguchi K
    Am J Gastroenterol; 2006 Dec; 101(12):2752-9. PubMed ID: 17026566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
    Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
    J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C infection and diabetes.
    Noto H; Raskin P
    J Diabetes Complications; 2006; 20(2):113-20. PubMed ID: 16504840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.
    Merchante N; Macías J; Ramayo E; Vergara S; García-García JA; Mira JA; Corzo JE; Gómez-Mateos JM; Lozano F; Pineda JA
    J Viral Hepat; 2006 Jul; 13(7):449-56. PubMed ID: 16792538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence and clinical significance of diabetes mellitus in patients with liver cirrhosis].
    Kwon SY
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):205-11. PubMed ID: 14515038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic disorders and chronic viral disease: the case of HIV and HCV.
    Slama L; Le Camus C; Serfaty L; Pialoux G; Capeau J; Gharakhanian S
    Diabetes Metab; 2009 Feb; 35(1):1-11. PubMed ID: 19046914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression.
    Alberstein M; Zornitzki T; Zick Y; Knobler H
    J Viral Hepat; 2012 Jan; 19(1):65-71. PubMed ID: 22187946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.
    Bernsmeier C; Duong FH; Christen V; Pugnale P; Negro F; Terracciano L; Heim MH
    J Hepatol; 2008 Sep; 49(3):429-40. PubMed ID: 18486982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
    Kita Y; Mizukoshi E; Takamura T; Sakurai M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
    Metabolism; 2007 Dec; 56(12):1682-8. PubMed ID: 17998021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad.
    Knobler H; Schattner A
    QJM; 2005 Jan; 98(1):1-6. PubMed ID: 15625348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: chronic hepatitis C--natural history and cofactors.
    Alberti A; Vario A; Ferrari A; Pistis R
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():74-8. PubMed ID: 16225479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.